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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not the use of
fasical manipulative therapy helps to improve overall asthma quality of life by decreasing asthma
symptoms.
Study Design: Review of two randomized controlled trials (RCTs) and one case study, published
between 2005-current, all in the English language.
Data Sources: Two randomized controlled trials (RCTs) and one case study, all of which
evaluate the effectiveness of fascial manipulative therapy as it pertains to asthma quality of life.
All studies were found using PubMed.
Outcomes Measured: The outcomes measured were an improvement of asthma quality of life
pertaining to asthma symptoms. These improvements were based on verbal reports given by
patients and/or guardians, asthma quality of life questionnaires, and PFTs related to morbidity
and mortality.
Results: The RCT by Mehl-Madrona et al. and the case study by Gillespie both demonstrate that
the use of fascial manipulation therapy help to improve asthma quality of life by decreasing
asthma symptoms. While Guiney et al. did not demonstrate a decrease in morbidity and mortality
associated with an increase in PFTs, the study does report patients “feeling better” after receiving
fascial manipulation therapy.
Conclusions: The results of this review demonstrate that there is evidence to support that the use
of fascial manipulation therapy can improve overall asthma quality of life by helping to decrease
asthma symptoms. While there was no documented decrease in morbidity and mortality, all three
studies showed that the use of fascial manipulation therapy, such as craniosacral and myofascial
release Osteopathic Manipulative Treatment (OMT), can release myofascial tension and help
patients to “breathe better”.
Key Words: Asthma, Manipulation Therapy
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INTRODUCTION
Asthma is a chronic inflammatory disorder of the lungs. An asthma attack is
characterized by inflammation leading to reversible obstruction of the airways, resulting in a
difficulty in breathing.4 In 2011, the Center for Disease Control and Prevention reported that in
the US alone there were approximately 18.9 million adults and 7.1 million children living with
asthma.6 These numbers account for 8.2% of the total adult population and 9.5% of the total
children population.6 In 2010 the CDC reported that 14.2 million Americans visited their primary
care physician office with asthma as their primary diagnosis and another 1.8 million Americans
visited the emergency department with asthma as their primary diagnosis.6 With the number of
medical visits for asthma related complaints it is not surprising that asthma has an estimated
annual healthcare cost of $56.0 billion.5
The severity of asthma varies from patient to patient. Asthma can range from mild to
severe and life threatening, leading to death if not promptly and properly dealt with. The
strongest predisposing factor of asthma is atopy, a genetic disposition to develop an allergic
reaction. Common allergens, prone to triggering an asthma attack, include house dust mites,
cockroaches, animal dander, seasonal pollens, and cigarette smoke.4 An asthma attack can be
initiated by either extrinsic, allergic, or intrinsic, non-allergic, factors. Exposure to such factors
leads to airway inflammation by a variety of mechanisms including: cellular infiltration by
eosinophils, neutrophils and lymphocytes; goblet cell hyperplasia leading to an increase in
mucus production; thickening of the basement membrane due to collagen deposition;
hypertrophy of bronchial smooth.4 All such mechanisms cause a narrowing of the airways
leading to classic symptoms such as wheezing, dyspnea, chest tightness, coughing, and excess
sputum production.4
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Conventional asthma treatment is based on the severity of a patient’s asthma and involves
the use of various types of pharmacologic agents to reduce inflammation and control asthma
symptoms. Quick-relief medications for acute asthma exacerbations include inhaled short-acting
beta-2-agonists and anticholinergics.4 Long-term control medications intended for better overall
control of asthma include systemic corticosteroids, inhaled long-acting beta-2-agonists, inhaled
long-acting anticholinergics, leukotriene modifiers, phosphodiesterase inhibitors,
immunomodulators, and combination medications.4
While there is currently no cure for asthma, all of the above listed medications have been
demonstrated to help control asthma by reducing symptoms. Nevertheless, there is still a pursuit
for an intervention that will help to further reduce asthma symptoms without the use of
pharmacologic agents. This paper evaluates two randomized controlled trials and one case study
in determining the efficacy of fascial manipulative therapy in improving asthma quality of life by
decreasing asthma symptoms. The term fascial manipulative therapy encompasses osteopathic
manipulative (OM) techniques including rib raising, muscle energy for ribs, myofascial release,
and craniosacral therapy (CST). Andrew Taylor Still, M.D., D.O. founded osteopathic medicine
in the 19th century on the basis that there is a myofascial system that links all parts of the body.
Andrew Taylor Still developed techniques which involved manipulation of the myofascial
system to “improve circulation and correct altered mechanics” of the body to treat illness and
disease.8 Osteopathic manipulative treatment (OMT) has long been used by osteopathic doctors
to provide relief for muscle aches and pains with the use of stretching, gentle pressure, and
resistance.7 These techniques are now being used for trial with other health problems such as
asthma, carpal tunnel syndrome, and migraines, among others, to complement or even replace
pharmacological agents and surgery.7
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OBJECTIVE
The objective of this selective EBM review is to determine whether or not the use of
fascial manipulative therapy helps to improve overall asthma quality of life by decreasing asthma
symptoms.

METHODS
This review includes two randomized controlled trials (RCTs) and one case study, all of
which evaluate the effectiveness of fascial manipulative therapy as it pertains to asthma quality
of life. The population studied includes males and females ages 5-80 years old who have been
previously diagnosed with asthma. The interventions used were OMT techniques that included
craniosacral therapy and myofascial release therapy. Mehl-Madrona et al. used 12 sessions
lasting 45 minutes each over a six week period of craniosacral therapy.3 Guiney et al. used
Osteopathic manipulative treatment (OMT) including rib raising, muscle energy for ribs, and
myofascial release.2 Gillespie used craniosacral fascial therapy at seven one-hour visits during
which the diaphragm, lungs, tracheobronchial tree, throat, neck, cranium, and nasal sinuses were
manipulated to relieve soft tissue strain and free the respiratory system.1 The comparisons
studied included prior use of standard asthma medications such as anti-inflammatory drugs
(corticosteroids) and bronchodilators, as well as comparison to “sham procedures” performed by
allopathic physicians to account for a “therapeutic touch” variable. Measured outcomes
comprised of improvement of asthma quality of life as reported by participants and also a
possible decrease in asthma related morbidity and mortality rates as measured by increased
pulmonary function.
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Table 1 – demographics & Characteristics of included studies
Study

Gillespie,
2008 (1)

Guiney,
2005 (2)

MehlMadrona,
2007 (3)

Type

Case
Study

RCT

RCT

#
Pts

1

140

89

Age
(yrs)

9
y/o

5-17
y/o

2080
y/o

Inclusion
Criteria

9 y/o Caucasian
boy with a
primary
diagnosis of
advanced
asthma

Asthmatic
children of
African
American or
Hispanic race
between the
ages of 5 and 17
years old
selected from
the pediatric
asthma clinic of
Peninsula
Hospital Center
in Far
Rockaway, NY.
Meet the criteria
for diagnosis of
asthma as
defined by the
National Heart,
Lung, and Blood
Institute
National Asthma
Education and
Prevention
Program; Class
II through IV
asthma sufferers
were included

Exclusion Criteria

N/A

Patients in acute
distress; Patients
who demonstrated
a lack of
cooperation with
study protocols –
or were otherwise
unable to
participate in
measuring PEF;
older than 18 y/o
or younger than 4
y/o
Under 18 y/o;
acupuncture or
craniosacral
therapy in past 6
months; pregnant;
on steroids
unrelated to
asthma; diagnosis
of only mild
intermittent
asthma; lifethreatening
conditions

W/D

Interventions

0

Craniosacral fascial
therapy: Seven onehour visits during
which the diaphragm,
lungs, tracheobronchial
tree, throat, neck,
cranium, and nasal
sinuses were
manipulated to relieve
soft tissue strain and
free the respiratory
system.

0

Osteopathic
manipulative treatment
(OMT) including rib
raising, muscle energy
for ribs, and
myofascial release VS.
“Sham procedure”
performed by an
allopathic physician
simulating OMT in
order to control for a
“therapeutic touch”
variable.

21

12 sessions lasting 45
minutes each over a six
week period of
craniosacral therapy
vs. attention control or
standard of care
control.
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Keywords used in the searches were “asthma” and “manipulation therapy”. All articles
were published in peer-reviewed journals and in the English language. The articles were
researched via PubMed and selected based on their relevance to my clinical question and if they
included patient oriented outcomes.
Inclusion criteria included: studies were randomized controlled trials or case studies
published between 2005-current, patients between the ages of 5-80 years old with a previous
diagnosis of asthma as defined by the National Heart, Lung, and Blood Institute National Asthma
Education and Prevention Program. Exclusion criteria included: patients ages <5 years old or
>80 years old, patients in acute distress, patients involved in other research studies, who were
pregnant, taking steroids unrelated to asthma, or subjects with life-threatening conditions or
serious psychiatric conditions that would interfere with their ability to participate in the study
and follow-up period. Summary statistics were reported using p-value and t-test.
OUTCOMES MEASURED
The outcomes measured an improvement of asthma quality of life pertaining to asthma
symptoms. Gillespie measured an improvement of asthma quality of life based on reports by the
patient and patient’s mother relating to an improvement in symptoms and a decrease in
frequency of asthma attacks. Mehl-Madrona et al. measured outcomes using an asthma quality of
life questionnaire and a medication form which the patient reported the name, dose, and
frequency of medication use. The asthma quality of life questionnaires were analyzed using
independent samples t tests, difference scores comparing pretreatment baseline, posttreatment, 3month follow-up, and 6-month follow-up. One-way analysis of variance was then performed
with post hoc tests with P values adjusted by Schade correction for multiple comparisons.

Mecouch, Fascial Manipulative Therapy & Asthma 6
Guiney et al. used patient’s symptoms in correlation with PEFs to estimate pulmonary function
as a predictor of asthma related morbidity and mortality.
RESULTS
Results from two randomized controlled trials and one case study are evaluated in this
review. The demographics and characteristics of the three studies reviewed are displayed in
Table 1. All three studies contained continuous data that could not be converted to dichotomous
format. Test statistics reported by the authors include p-values, mean changes from baseline,
difference scores, independent t-tests, and one-way analysis of variance with post hoc tests with
P values adjusted by the Schade correction for multiple comparisons.
In the case study by Gillespie1, a nine-year-old Caucasian boy presented with a known
diagnosis of asthma. Since the age of two months old the participant had been on various
regiments for asthma treatment including albuterol, levalbuterol hydrochloride, cromolyn,
fluticasone propionate and salmeterol, montelukast, and prednisone.1 The intervention in this
case study was seven one-hour visits consisting of craniosacral fascial therapy to release
craniosacral and fascial strains to improve asthma symptoms over a 30 day period.1 In this study
the patient was compliant with the treatment schedule outlined and developed no adverse effects
from treatment. Both the patient and the patient’s mother reported improvement of asthma
symptoms verbally. After only one treatment session the patient reported being able to “breathe
more freely” and the patient’s mother stated that the boy was more verbally active the day after
treatment.1 At the third visit the patient’s mother stated that she had stopped the all asthma
medication after the first visit and that the child had not needed to take any of his prescribed
medication due to asthma symptoms in the past two weeks.1 After the fourth visit the mother
reports that the cough the child normally develops in the middle of winter was gone despite the
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fact the child remained off of his asthma medications.1 By the end of the 30 day treatment period
the patient’s mother reported that the child was still off of his medications, was cough free, and
was able to play football outside on one of the coldest days of winter without developing asthma
symptoms.1
The RCT by Mehl-Madrona et al.3 assessed the effects of craniosacral therapy on asthma
quality of life. The intervention involved 12 standard craniosacral therapy treatments, each
treatment lasted approximately 45 minutes, over a six week period.3 There were a total of 89
participants in the study. The number of participants at the end of the study was 68, accounting
for a 24% loss.3 No participant dropped out of the study due to adverse effects from the
treatment. No adverse effects were reported by any participant in the entire study.3 A modified
intention to treat analysis was used. If a participant completed one treatment and then withdrew
from the study they were invited back to have a posttreatment analysis, otherwise they were not
included in the final results analysis.3 The craniosacral therapy treatment group was compared to
two control groups: a standard of care control group in which participants were instructed to
maintain their normal asthma care regimens and an attention control group in which participants
received six sessions of sham craniosacral therapy and six one-on-one educational classes. Due
to the small group sizes at the end of the study the groups were collapsed into “treatment” and
“control” groups for analysis purposes.3 Asthma quality of life questionnaires were completed by
each participant on four occasions: pretreatment, post-treatment, a three-month follow-up, and a
six-month follow-up. Asthma quality of life questionnaire mean scores for the treatment and
control groups are displayed in Table 2. Difference scores were calculated to reduce withinsubjects variance. There are statistically significant differences between the control and treatment
groups when comparing asthma quality of life pretreatment and posttreatment scores (Table 2).
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With the confidence interval set at 95% the greatest variance was noted between the difference
score pretreatment and post-treatment with a mean difference of 3.61 and a P value of 0.004
(Table 2).3 Although not as ample as the immediate post-treatment score, the three month followup still displays a statistically significant difference.3

Table 2: Mehl-Madrona et al3: Comparisons of Means Between Asthma Quality of Life
(part 1) Scores and Difference Scores From Baseline Across Assessment Periods

The RCT by Guiney et al.2 evaluated the effects of osteopathic manipulative treatment
(OMT) on pediatric patients with asthma. This study contained 140 participants, all of which
remained in the study until its conclusion. The participants were divided into two groups: 90
were placed in the OMT group and 50 were placed in the control group.2 Guiney et al. postulated
that OMT may be a treatment method to help decrease asthma related morbidity and mortality in
pediatric patients.2 Guiney et al. measured PEFs to estimate pulmonary function as an indirect
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measure of morbidity and mortality. The treatment group received OMT, which included rib
raisings; muscle energy for ribs, and myofascial release while the control group received a sham
procedure performed by an allopathic physician. PEFs were measured before and after the OMT
or sham procedure. Results were then analyzed using t tests (Table 3).2 Based on osteopathic
principles, the use of OMT can be used to maximize the motion of the musculoskeletal system
which improves the overall function of the respiratory system and allows the patient to breathe
better.2 The use of OMT was able to increase pulmonary function with a mean of 13 L per
minute and percent difference of 4.8% in PEFs compared to the control group which had a mean
increase of 0.3 L per minute in pulmonary function and a percent difference of 1.4% in PEFs
(Table 3).2 There was a positive correlation noted between the increase in pulmonary function
and the patients “feeling better.”2 However, there was no demonstration of a significant decrease
in morbidity and mortality.2 The authors suggest that further testing with a larger sample size and
long-term follow up is needed.2

Table 3: Guiney et al.2: Peak Expiratory Flow Rates for Pediatric Patients with Asthma
Summary of t Test Analysis (Liters Per Minute)
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DISCUSSION
This systemic review investigated the effectiveness of fascial manipulation therapy, such
as OMT, on asthma quality of life as demonstrated in two RCTs and one case study. The case
study by Gillespie and the RCT by Guiney et al evaluated pediatric patients with asthma over the
age of 5 years old. The remaining RCT by Mehl-Madrona et al evaluated adult patients with
asthma between the ages of 20 and 80 years old. Each of the three studies described a positive
correlation between fascial manipulation therapy and improvement of asthma quality of life.
A limitation of this literature review is that it involved search parameters that only
included publications from 2005 to January 2013, which excluded any prior publications. Each
of the included studies had their own limitations. The case study by Gillespie, while it
demonstrated a profound relationship between the use of craniosacral therapy as an effective
approach to improving asthma symptoms, only contained a sample size of one. Further research
is needed in order to determine a more definitive relationship.
Guiney et al. contained participants that were selected from the pediatric asthma clinic of
Peninsula Hospital Center in Far Rockaway, NY. A sample size containing a wider population
distribution may help to strengthen the validity of the results. Another limitation in the RCT by
Guiney et al. is that the study only included one session of either OMT or the sham procedure.
Therefore, the study was unable to assess long-term treatment effects.
Mehl-Madrona et al. contained a moderately high dropout rate, 24% lost, which is source
of potential bias. Mehl-Madrona et al. also had an unforeseeable and uncontrollable situation that
may have affected the outcomes. This situation was the fact that the 9/11 attacks occurred in the
middle of the intervention period of the study. Because environmental factors can play a
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significant role in asthma symptoms, the increased levels of smoke and dust from the 9/11
attacks may have altered the results.
Osteopathic manipulation treatment (OMT), which includes techniques such as
craniosacral therapy and myofascial release, has been in use since the 19th century. While OMT
is classically known for its treatment of low back pain and musculoskeletal abnormalities,
according to the American Osteopathic Association, OMT can also be used in the treatment of
asthma, carpal tunnel syndrome, menstrual pain, sinus disorders, and migraines.7 The American
Osteopathic Association also reports that OMT is covered by most insurance plans.7

CONCLUSIONS
Asthma is a chronic condition that may range from only mild symptoms to deadly
attacks. With 16 million Americans visiting either their primary care physician or an emergency
department in 2010 due to a chief complaint of asthma related symptoms and an estimated
annual healthcare cost of $56.0 billion, it is clear that further intervention is required in order to
help improve their asthma quality of life.5,6 The results of this review demonstrate that there is
evidence to support that the use of fascial manipulation therapy can improve overall asthma
quality of life by helping to decrease asthma symptoms. While there was no documented
decrease in morbidity and mortality, all three studies showed that the use of fascial manipulation
therapy, such as craniosacral and myofascial release OMT, can release myofascial tension and
help patients to “breathe better”. As mentioned in Guiney et al. future studies may benefit from
the use of a single osteopathic physician performing OMT in order to eliminate potential
differences in OMT skill levels and techniques.2
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